Assessing the effect of platelet infusion in reducing hemorrhage during CABG surgery in patients under plavix treatment

Not Applicable

• Conditions: ?????? ???? ?????.; Other specified complications of cardiac and vascular prosthetic devices, implants and grafts; T82.8

• Registration Number: IRCT20200902048590N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Using plavix
Need for coronary artery bypass
Being unable to hold plavix
Informed consent

Exclusion Criteria

Patient's dissatisfaction and the desire to cut off cooperation
Incidence of complications

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bleeding amount. Timepoint: 1, 6, 12, 24, and 48 hours after surgery. Method of measurement: Assessing the amount of packed cell needed.